Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lyrica Generics Likely Delayed By A Pfizer Labeling Supplement
Jul 25 2019
•
By
Derrick Gingery
A labeling update approved just before patent expiry may have caused Lyrica generics to be cleared later than expected in the US . • Source: Shutterstock
More from Generics
More from Biosimilars & Generics